Webhaber
Lilly shares slip as FDA seeks more Alzheimer’s drug data

Lilly shares slip as FDA seeks more Alzheimer’s drug data

Eli Lilly shares slipped Friday morning after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment. Lilly said the Food and Drug Administration wants information from at least 100 patients who received a minimum of 12 months of continued treatment on donanemab. […]

National Post National Post | Go to detail of news source

National Post , Benzer haberler

National Post Pope arrives in volatile South Sudan for ‘pilgrimage of peace’ Pope arrives in volatile South Sudan for ‘pilgrimage of peace’
National Post UN peacekeepers have departed a rebel stronghold in northern Mali early as violence increases UN peacekeepers have departed a rebel stronghold in northern Mali early as violence increases
National Post Ottawa Senators assistant coach Bob Jones diagnosed with ALS Ottawa Senators assistant coach Bob Jones diagnosed with ALS
National Post Stolen money evidence allowed in Alex Murdaugh murder trial Stolen money evidence allowed in Alex Murdaugh murder trial
National Post Federal Reserve Events Federal Reserve Events
National Post Tommy Paul beats Ben Shelton, Novak Djokovic next in Aussie semis Tommy Paul beats Ben Shelton, Novak Djokovic next in Aussie semis